Cargando…

BPIFB4 Circulating Levels and Its Prognostic Relevance in COVID-19

Aging and comorbidities make individuals at greatest risk of COVID-19 serious illness and mortality due to senescence-related events and deleterious inflammation. Long-living individuals (LLIs) are less susceptible to inflammation and develop more resiliency to COVID-19. As demonstrated, LLIs are ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciaglia, Elena, Lopardo, Valentina, Montella, Francesco, Sellitto, Carmine, Manzo, Valentina, De Bellis, Emanuela, Iannaccone, Teresa, Franci, Gianluigi, Zannella, Carla, Pagliano, Pasquale, Di Pietro, Paola, Carrizzo, Albino, Vecchione, Carmine, Conti, Valeria, Filippelli, Amelia, Puca, Annibale Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	THE JOURNAL OF GERONTOLOGY: Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436991/ https://www.ncbi.nlm.nih.gov/pubmed/34396395 http://dx.doi.org/10.1093/gerona/glab208

Ejemplares similares

The Role of BPIFB4 in Immune System and Cardiovascular Disease: The Lesson from Centenarians
por: Montella, Francesco, et al.
Publicado: (2021)

Gender Differences Associated with the Prognostic Value of BPIFB4 in COVID-19 Patients: A Single-Center Preliminary Study
por: Lopardo, Valentina, et al.
Publicado: (2022)

Circulating BPIFB4 Levels Associate With and Influence the Abundance of Reparative Monocytes and Macrophages in Long Living Individuals
por: Ciaglia, Elena, et al.
Publicado: (2020)

Transfer of the longevity-associated variant of BPIFB4 gene rejuvenates immune system and vasculature by a reduction of CD38(+) macrophages and NAD(+) decline
por: Ciaglia, Elena, et al.
Publicado: (2022)

New Insights for BPIFB4 in Cardiovascular Therapy
por: Dossena, Marta, et al.
Publicado: (2020)

The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum–microglia crosstalk preventing disease progression in a mouse model of Huntington’s disease
por: Di Pardo, Alba, et al.
Publicado: (2020)

The Longevity-Associated Variant of BPIFB4 Reduces Senescence in Glioma Cells and in Patients’ Lymphocytes Favoring Chemotherapy Efficacy
por: Puca, Annibale Alessandro, et al.
Publicado: (2022)

Serum BPIFB4 levels classify health status in long-living individuals
por: Villa, Francesco, et al.
Publicado: (2015)

A Model of Evolutionary Selection: The Cardiovascular Protective Function of the Longevity Associated Variant of BPIFB4
por: Villa, Francesco, et al.
Publicado: (2018)

SARS-CoV-2 Lysate Stimulation Impairs the Release of Platelet-like Particles and Megakaryopoiesis in the MEG-01 Cell Line
por: Lopardo, Valentina, et al.
Publicado: (2023)

The expression of the BPIFB4 and CXCR4 associates with sustained health in long-living individuals from Cilento-Italy
por: Spinetti, Gaia, et al.
Publicado: (2017)

LAV-BPIFB4 associates with reduced frailty in humans and its transfer prevents frailty progression in old mice
por: Malavolta, Marco, et al.
Publicado: (2019)

The anti-ageing molecule sirt1 mediates beneficial effects of cardiac rehabilitation
por: Russomanno, Giusy, et al.
Publicado: (2017)

Correction for: LAV-BPIFB4 associates with reduced frailty in humans and its transfer prevents frailty progression in old mice
por: Malavolta, Marco, et al.
Publicado: (2019)

PD-L1 Dysregulation in COVID-19 Patients
por: Sabbatino, Francesco, et al.
Publicado: (2021)

LAV-BPIFB4 isoform modulates eNOS signalling through Ca(2+)/PKC-alpha-dependent mechanism
por: Spinelli, Chiara Carmela, et al.
Publicado: (2017)

Endothelial nitric oxide synthase, vascular integrity and human exceptional longevity
por: Puca, Annibale Alessandro, et al.
Publicado: (2012)

COVID-19 Infection and Circulating ACE2 Levels: Protective Role in Women and Children
por: Ciaglia, Elena, et al.
Publicado: (2020)

Cardiac Rehabilitation Increases SIRT1 Activity and β-Hydroxybutyrate Levels and Decreases Oxidative Stress in Patients with HF with Preserved Ejection Fraction
por: Corbi, Graziamaria, et al.
Publicado: (2019)

A rare genetic variant of BPIFB4 predisposes to high blood pressure via impairment of nitric oxide signaling
por: Vecchione, Carmine, et al.
Publicado: (2017)

Longevity-Associated Variant of BPIFB4 Confers Neuroprotection in the STHdh Cell Model of Huntington Disease
por: Cattaneo, Monica, et al.
Publicado: (2022)

Different Prognostic Role of Soluble PD-L1 in the Course of Severe and Non-Severe COVID-19
por: Sabbatino, Francesco, et al.
Publicado: (2023)

Author Correction: A rare genetic variant of BPIFB4 predisposes to high blood pressure via impairment of nitric oxide signaling
por: Vecchione, Carmine, et al.
Publicado: (2019)

Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters
por: Iannaccone, Teresa, et al.
Publicado: (2021)

Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics
por: Conti, Valeria, et al.
Publicado: (2020)

Opposite Response to Vitamin K Antagonists: A Report of Two Cases and Systematic Review of Literature
por: Conti, Valeria, et al.
Publicado: (2022)

Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular Diseases
por: Forte, Maurizio, et al.
Publicado: (2016)

Identification of Drug Interaction Adverse Events in Patients With COVID-19: A Systematic Review
por: Conti, Valeria, et al.
Publicado: (2022)

Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes
por: Conti, Valeria, et al.
Publicado: (2020)

The longevity-associated BPIFB4 gene supports cardiac function and vascularization in ageing cardiomyopathy
por: Cattaneo, Monica, et al.
Publicado: (2023)

A G613A missense in the Hutchinson’s progeria lamin A/C gene causes a lone, autosomal dominant atrioventricular block
por: Villa, Francesco, et al.
Publicado: (2014)

Effect of Tocilizumab in Reducing the Mortality Rate in COVID-19 Patients: A Systematic Review with Meta-Analysis
por: Conti, Valeria, et al.
Publicado: (2021)

The inflammatory protein Pentraxin 3 in cardiovascular disease
por: Fornai, Francesco, et al.
Publicado: (2016)

Experimental Pharmacotherapy for COVID-19: The Latest Advances
por: Pagliano, Pasquale, et al.
Publicado: (2021)

Effects of Human LAV-BPIFB4 Gene Therapy on the Epigenetic Clock and Health of Aged Mice
por: Giuliani, Maria Elisa, et al.
Publicado: (2023)

Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study
por: Giudice, Valentina, et al.
Publicado: (2020)

Blood biomarkers role in acute ischemic stroke patients: higher is worse or better?
por: Kisialiou, Aliaksei, et al.
Publicado: (2012)

Exome sequencing of a family with lone, autosomal dominant atrial flutter identifies a rare variation in ABCB4 significantly enriched in cases
por: Maciąg, Anna, et al.
Publicado: (2015)

PTX3: an inflammatory protein modulating ultrastructure and bioenergetics of human endothelial cells
por: Carrizzo, Albino, et al.
Publicado: (2019)

Molecules and Mechanisms to Overcome Oxidative Stress Inducing Cardiovascular Disease in Cancer Patients
por: Sabbatino, Francesco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ef2jsr8ip2tg9i7f47dn3ouc5t